Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from rheumatoid arthritis (RA) synovial cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 342.00 | |
5 mg | In stock | $ 769.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,680.00 | |
50 mg | In stock | $ 2,290.00 | |
100 mg | In stock | $ 2,970.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 781.00 |
Description | S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from rheumatoid arthritis (RA) synovial cells. |
In vitro | In vitro protein binding of S-methyl-KE-298 is high in rat (>97%), dog (>89%) and human plasma (>99%), respectively[2]. |
Molecular Weight | 252.33 |
Formula | C13H16O3S |
CAS No. | 143584-75-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (396.31 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
S-methyl-KE-298 143584-75-2 Metabolism Proteases/Proteasome MMP Drug Metabolite inhibit M-2 SmethylKE298 Matrix metalloproteinases Inhibitor S-methyl-KE 298 S methyl KE 298 S-methyl-KE298 M 2 inhibitor